These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 14759119)

  • 1. Aspergillosis of the temporomandibular joint following irradiation of the parotid region: a case report.
    Lo WL; Chang RC; Yang AH; Kao SY
    Int J Oral Maxillofac Surg; 2003 Oct; 32(5):560-2. PubMed ID: 14759119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rhinocerebral mycosis in immunocompromised patients. A case report and review of the literature.
    Schmidt JM; Poublon RM
    Rhinology; 1998 Jun; 36(2):90-3. PubMed ID: 9695166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Invasive aspergillosis treated with adjunctive hyperbaric oxygenation: a retrospective clinical series at a single institution.
    García-Covarrubias L; Barratt DM; Bartlett R; Metzinger S; Van Meter K
    South Med J; 2002 Apr; 95(4):450-6. PubMed ID: 11958246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Septic arthritis of the temporomandibular joint caused by Aspergillus flavus infection as a complication of otitis externa.
    Varghese L; Chacko R; Varghese GM; Job A
    Ear Nose Throat J; 2015 Mar; 94(3):E24-6. PubMed ID: 25738723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fungal malignant otitis externa treated with hyperbaric oxygen.
    Ling SS; Sader C
    Int J Infect Dis; 2008 Sep; 12(5):550-2. PubMed ID: 18508401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Strategy of following voriconazole versus amphotericin B therapy with other licensed antifungal therapy for primary treatment of invasive aspergillosis: impact of other therapies on outcome.
    Patterson TF; Boucher HW; Herbrecht R; Denning DW; Lortholary O; Ribaud P; Rubin RH; Wingard JR; DePauw B; Schlamm HT; Troke P; Bennett JE; ;
    Clin Infect Dis; 2005 Nov; 41(10):1448-52. PubMed ID: 16231256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liposomal amphotericin B (AmBisome) efficacy in confirmed invasive aspergillosis and other filamentous fungal infections in immunocompromised hosts: a pooled analysis.
    Cordonnier C; Bresnik M; Ebrahimi R
    Mycoses; 2007 May; 50(3):205-9. PubMed ID: 17472618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Osteomyelitis of the temporomandibular joint.
    Winslow CP; Dichard A; McGuire KA
    Am J Otolaryngol; 2001; 22(2):142-5. PubMed ID: 11283831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperbaric oxygen in the treatment of invasive fungal infections: a single-center experience.
    Segal E; Menhusen MJ; Shawn S
    Isr Med Assoc J; 2007 May; 9(5):355-7. PubMed ID: 17591371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperbaric oxygen in the therapeutic management of osteoradionecrosis of the facial bones.
    Vudiniabola S; Pirone C; Williamson J; Goss AN
    Int J Oral Maxillofac Surg; 2000 Dec; 29(6):435-8. PubMed ID: 11202324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multimodality surgical and hyperbaric management of mandibular osteoradionecrosis.
    Freiberger JJ; Yoo DS; de Lisle Dear G; McGraw TA; Blakey GH; Padilla Burgos R; Kraft K; Nelson JW; Moon RE; Piantadosi CA
    Int J Radiat Oncol Biol Phys; 2009 Nov; 75(3):717-24. PubMed ID: 19328634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aspergillus susceptibility testing in patients with cancer and invasive aspergillosis: difficulties in establishing correlation between in vitro susceptibility data and the outcome of initial amphotericin B therapy.
    Lionakis MS; Lewis RE; Chamilos G; Kontoyiannis DP
    Pharmacotherapy; 2005 Sep; 25(9):1174-80. PubMed ID: 16164392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination antifungal therapy for invasive aspergillosis: can it replace high-risk surgery at the skull base?
    Panda NK; Saravanan K; Chakrabarti A
    Am J Otolaryngol; 2008; 29(1):24-30. PubMed ID: 18061828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Poor efficacy of amphotericin B-based therapy in CNS aspergillosis.
    Schwartz S; Ruhnke M; Ribaud P; Reed E; Troke P; Thiel E
    Mycoses; 2007 May; 50(3):196-200. PubMed ID: 17472616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amphotericin B lipid complex versus liposomal amphotericin B monotherapy for invasive aspergillosis in patients with hematologic malignancy.
    Hachem RY; Boktour MR; Hanna HA; Husni RN; Torres HA; Afif C; Kontoyiannis DP; Raad II
    Cancer; 2008 Mar; 112(6):1282-7. PubMed ID: 18224662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Osteoradionecrosis of the mandible: treatment outcomes and factors influencing the progress of osteoradionecrosis.
    Oh HK; Chambers MS; Martin JW; Lim HJ; Park HJ
    J Oral Maxillofac Surg; 2009 Jul; 67(7):1378-86. PubMed ID: 19531406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radical radiotherapy for treatment of malignant parotid tumours: a single centre experience 1995-2005.
    Bhide SA; Miah A; Barbachano Y; Harrington KJ; Newbold K; Nutting CM
    Br J Oral Maxillofac Surg; 2009 Jun; 47(4):284-9. PubMed ID: 19193477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amphotericin B lipid complex in the management of invasive aspergillosis in immunocompromised patients.
    Chandrasekar PH; Ito JI
    Clin Infect Dis; 2005 May; 40 Suppl 6():S392-400. PubMed ID: 15809925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Temporomandibular joint septic arthritis with secondary condylar resorption].
    Constant M; Nicot R; Maes JM; Raoul G; Ferri J
    Rev Stomatol Chir Maxillofac Chir Orale; 2016 Sep; 117(4):294-7. PubMed ID: 27522243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Free flap coverage of extensive soft tissue defect in cutaneous aspergillosis: a case report.
    Heo CY; Eun SC; Baek RM; Minn KW
    J Korean Med Sci; 2008 Oct; 23(5):920-3. PubMed ID: 18955807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.